Skip to main content

Want a detailed portfolio tracker?

Ikena Oncology (IMA) P/E (2021 - 2026)

Ikena Oncology (IMA) P/E from Mar 26, 2021 to Jul 21, 2026. The TTM Ikena Oncology (IMA) P/E is -0.83. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ikena Oncology (IMA)

YearP/EChange
2026-0.83-10.05%
2025-0.92-57.49%
2024-2.16+73.48%
2023-1.25-32.82%
2022-1.86-85.91%
2021-13.18N/A

Comparison Ikena Oncology (IMA) P/E with competitors

Ikena Oncology (IMA) P/E is -0.83.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.21%
NBYStablecoin Development Corp0.00-100.52%
ENLVEnlivex Ltd0.07-109.04%
FGENFibroGen Inc0.24-129.01%
CHRSCoherus Biosciences Inc0.85-202.55%
FBIOFortress Biotech Inc0.95-214.69%
ORMPOramed Pharmaceuticals Inc1.50-281.65%
AGENAgenus Inc3.01-463.72%
INVAInnoviva Inc3.15-481.17%
VXRTVaxart Inc3.55-529.00%
CRMDCorMedix Inc3.63-538.51%
CVACCureVac N.V.4.45-637.28%
GLPGGalapagos NV4.86-687.21%
SRPTSarepta Therapeutics Inc4.88-690.02%
ABEOAbeona Therapeutics Inc5.39-751.10%
ABUSArbutus Biopharma Corp5.60-776.25%
ZVRAZevra Therapeutics Inc5.89-811.49%
SPROSpero Therapeutics Inc6.23-852.73%
CGENCompugen Ltd6.31-863.06%
RIGLRigel Pharmaceuticals6.87-930.51%
SLXNSilexion Therapeutics Corp7.30-981.76%
OMEROmeros Corporation9.26-1218.95%
AUPHAurinia Pharmaceuticals Inc9.58-1258.38%
PLXProtalix BioTherapeutics Inc10.89-1416.22%
ACADAcadia Pharmaceuticals Inc11.73-1517.44%
TBPHTheravance Biopharma Inc12.26-1581.93%
ADMAAdma Biologics Inc12.42-1600.78%
HRMYHarmony Biosciences Holdings Inc13.82-1770.22%
SABSSAB Biotherapeutics Inc14.14-1808.42%
NAGENiagen Bioscience Inc14.82-1890.83%
INCYIncyte Corp15.82-2012.22%
REGNRegeneron Pharmaceuticals Inc15.86-2016.34%
PBYIPuma Biotechnology Inc17.32-2192.67%
CPRXCatalyst Pharmaceuticals Inc17.44-2207.61%
EXELExelixis Inc17.54-2219.54%
TGTXTG Therapeutics Inc18.97-2392.12%
MDXGMimedx Group Inc20.55-2583.85%
XOMAXOMA Royalty Corp22.87-2864.57%
ARGXArgen X SE24.30-3036.59%
CTMXCytomX Therapeutics Inc24.82-3099.81%
XOMAOXOMA Royalty Corp25.34-3163.10%
HALOHalozyme Therapeutics Inc25.62-3196.81%
XOMAPXOMA Royalty Corp25.67-3202.42%
VRTXVertex Pharmaceuticals Inc27.99-3483.37%
RPRXRoyalty Pharma plc - Class A28.69-3567.10%
SLNOSoleno Therapeutics Inc29.02-3606.71%
ASNDAscendis Pharma A/S30.09-3736.06%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4681.94%
APLSApellis Pharmaceuticals Inc39.02-4816.00%
BMRNBiomarin Pharmaceutical Inc42.21-5201.61%
KRYSKrystal Biotech Inc45.34-5580.09%
ONCBeiGene Ltd69.54-8504.47%
PHARPharming Group N.V.75.03-9167.39%
TECHBio-Techne Corp101.96-12422.41%
VCELVericel Corp109.92-13384.80%
ALNYAlnylam Pharmaceuticals Inc117.96-14356.94%
GMABGenmab140.29-17055.16%
TLXTelix Pharmaceuticals Ltd162.15-19697.35%
CORTCorcept Therapeutics Inc212.86-25825.38%